Burning Rock Biotech (BNR) Enterprise Value (2021 - 2023)

Burning Rock Biotech has reported Enterprise Value over the past 3 years, most recently at -$85.4 million for Q4 2023.

  • Quarterly results put Enterprise Value at -$85.4 million for Q4 2023, up 34.32% from a year ago — trailing twelve months through Dec 2023 was -$85.4 million (up 34.32% YoY), and the annual figure for FY2023 was -$86.7 million, up 37.12%.
  • Enterprise Value for Q4 2023 was -$85.4 million at Burning Rock Biotech, up from -$130.1 million in the prior quarter.
  • Over the last five years, Enterprise Value for BNR hit a ceiling of -$85.4 million in Q4 2023 and a floor of -$225.1 million in Q4 2021.
  • Median Enterprise Value over the past 3 years was -$130.1 million (2022), compared with a mean of -$146.9 million.
  • Biggest five-year swings in Enterprise Value: skyrocketed 42.2% in 2022 and later surged 34.32% in 2023.
  • Burning Rock Biotech's Enterprise Value stood at -$225.1 million in 2021, then skyrocketed by 42.2% to -$130.1 million in 2022, then surged by 34.32% to -$85.4 million in 2023.
  • The last three reported values for Enterprise Value were -$85.4 million (Q4 2023), -$130.1 million (Q4 2022), and -$225.1 million (Q4 2021) per Business Quant data.